Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ethanol | 30 | 2022 | 137 | 4.430 |
Why?
|
Intestinal Mucosa | 27 | 2020 | 220 | 3.470 |
Why?
|
Circadian Rhythm | 17 | 2022 | 280 | 2.160 |
Why?
|
Intestines | 17 | 2022 | 107 | 2.110 |
Why?
|
Alcoholism | 8 | 2022 | 83 | 1.920 |
Why?
|
Colon | 15 | 2023 | 148 | 1.910 |
Why?
|
Liver Diseases, Alcoholic | 8 | 2017 | 45 | 1.680 |
Why?
|
Gastrointestinal Microbiome | 12 | 2023 | 179 | 1.550 |
Why?
|
Permeability | 20 | 2021 | 134 | 1.350 |
Why?
|
Oxidative Stress | 10 | 2017 | 126 | 1.230 |
Why?
|
Epithelial Cells | 9 | 2022 | 87 | 1.160 |
Why?
|
Animals | 45 | 2023 | 4591 | 1.120 |
Why?
|
Cytochrome P-450 CYP2E1 | 3 | 2014 | 13 | 1.100 |
Why?
|
Central Nervous System Depressants | 6 | 2019 | 24 | 1.030 |
Why?
|
CLOCK Proteins | 7 | 2018 | 26 | 0.940 |
Why?
|
Alcohol Drinking | 7 | 2020 | 76 | 0.910 |
Why?
|
Mice | 23 | 2023 | 1617 | 0.890 |
Why?
|
Inflammation | 11 | 2021 | 344 | 0.870 |
Why?
|
Liver | 5 | 2017 | 173 | 0.850 |
Why?
|
Parkinson Disease | 7 | 2023 | 1164 | 0.810 |
Why?
|
Circadian Clocks | 5 | 2022 | 31 | 0.790 |
Why?
|
Stem Cells | 2 | 2017 | 46 | 0.770 |
Why?
|
Microbiota | 7 | 2023 | 105 | 0.750 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 200 | 0.730 |
Why?
|
Transcription Factors | 2 | 2011 | 156 | 0.710 |
Why?
|
Period Circadian Proteins | 5 | 2021 | 23 | 0.700 |
Why?
|
Mice, Inbred C57BL | 16 | 2023 | 444 | 0.680 |
Why?
|
Feces | 10 | 2023 | 98 | 0.680 |
Why?
|
Dysbiosis | 8 | 2022 | 64 | 0.670 |
Why?
|
Male | 41 | 2022 | 15633 | 0.660 |
Why?
|
Humans | 62 | 2023 | 29351 | 0.640 |
Why?
|
Organoids | 1 | 2017 | 8 | 0.640 |
Why?
|
Circadian Rhythm Signaling Peptides and Proteins | 3 | 2019 | 10 | 0.600 |
Why?
|
Nitric Oxide Synthase Type II | 5 | 2015 | 64 | 0.590 |
Why?
|
Endotoxemia | 7 | 2015 | 29 | 0.580 |
Why?
|
Disease Models, Animal | 11 | 2023 | 731 | 0.570 |
Why?
|
Bacterial Translocation | 2 | 2015 | 33 | 0.540 |
Why?
|
Intestinal Absorption | 6 | 2017 | 41 | 0.520 |
Why?
|
Gastrointestinal Tract | 5 | 2023 | 54 | 0.500 |
Why?
|
alpha-Synuclein | 2 | 2015 | 138 | 0.490 |
Why?
|
Fatty Acids, Volatile | 4 | 2023 | 30 | 0.490 |
Why?
|
Fatty Liver | 4 | 2018 | 30 | 0.470 |
Why?
|
Colonic Neoplasms | 2 | 2013 | 65 | 0.460 |
Why?
|
Caco-2 Cells | 9 | 2015 | 53 | 0.460 |
Why?
|
Gastrointestinal Diseases | 3 | 2019 | 43 | 0.460 |
Why?
|
Cartilage, Articular | 4 | 2015 | 524 | 0.440 |
Why?
|
Endotoxins | 1 | 2011 | 24 | 0.420 |
Why?
|
Digestive System | 1 | 2010 | 16 | 0.380 |
Why?
|
Probiotics | 2 | 2015 | 19 | 0.370 |
Why?
|
Chondrocytes | 3 | 2008 | 197 | 0.360 |
Why?
|
Mesoderm | 1 | 2009 | 19 | 0.360 |
Why?
|
Photoperiod | 4 | 2021 | 43 | 0.360 |
Why?
|
MicroRNAs | 4 | 2015 | 42 | 0.360 |
Why?
|
Aspirin | 1 | 2010 | 83 | 0.350 |
Why?
|
Multiple System Atrophy | 2 | 2022 | 42 | 0.350 |
Why?
|
ErbB Receptors | 1 | 2009 | 72 | 0.350 |
Why?
|
Cell Membrane Permeability | 4 | 2015 | 56 | 0.350 |
Why?
|
Neurons | 1 | 2011 | 374 | 0.330 |
Why?
|
Collagenases | 2 | 2005 | 20 | 0.330 |
Why?
|
Biomarkers, Tumor | 1 | 2009 | 175 | 0.330 |
Why?
|
Carrier Proteins | 3 | 2021 | 98 | 0.320 |
Why?
|
Membrane Glycoproteins | 3 | 2021 | 102 | 0.320 |
Why?
|
Work Schedule Tolerance | 2 | 2020 | 39 | 0.320 |
Why?
|
Gene Expression Regulation | 5 | 2019 | 288 | 0.310 |
Why?
|
Fatty Liver, Alcoholic | 3 | 2014 | 11 | 0.300 |
Why?
|
Immunity, Mucosal | 3 | 2019 | 29 | 0.300 |
Why?
|
Neurosecretory Systems | 2 | 2022 | 9 | 0.300 |
Why?
|
Middle Aged | 17 | 2021 | 9818 | 0.290 |
Why?
|
Macrophage-1 Antigen | 2 | 2007 | 10 | 0.290 |
Why?
|
Intestine, Small | 2 | 2017 | 33 | 0.290 |
Why?
|
Candida albicans | 2 | 2007 | 22 | 0.290 |
Why?
|
Colon, Sigmoid | 2 | 2017 | 18 | 0.280 |
Why?
|
Female | 20 | 2021 | 16205 | 0.280 |
Why?
|
Signal Transduction | 6 | 2019 | 486 | 0.280 |
Why?
|
Breast Neoplasms | 1 | 2009 | 328 | 0.280 |
Why?
|
Colitis | 2 | 2023 | 37 | 0.270 |
Why?
|
Chronobiology Disorders | 2 | 2017 | 14 | 0.270 |
Why?
|
Rats | 9 | 2020 | 857 | 0.260 |
Why?
|
Molecular Targeted Therapy | 2 | 2018 | 31 | 0.260 |
Why?
|
Metabolome | 2 | 2015 | 16 | 0.250 |
Why?
|
Volatile Organic Compounds | 2 | 2015 | 10 | 0.250 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2011 | 88 | 0.250 |
Why?
|
HIV Infections | 3 | 2018 | 970 | 0.240 |
Why?
|
Feeding Behavior | 3 | 2019 | 99 | 0.240 |
Why?
|
Aging | 3 | 2018 | 1599 | 0.230 |
Why?
|
STAT3 Transcription Factor | 1 | 2023 | 10 | 0.230 |
Why?
|
Musculoskeletal Diseases | 1 | 2023 | 41 | 0.230 |
Why?
|
Sucrose | 3 | 2011 | 17 | 0.230 |
Why?
|
Osteoarthritis | 3 | 2018 | 363 | 0.230 |
Why?
|
Mice, Knockout | 4 | 2022 | 306 | 0.220 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2022 | 11 | 0.220 |
Why?
|
Biomarkers | 5 | 2021 | 691 | 0.220 |
Why?
|
Osteogenesis | 1 | 2022 | 96 | 0.210 |
Why?
|
Propionates | 1 | 2022 | 12 | 0.210 |
Why?
|
CD18 Antigens | 1 | 2002 | 6 | 0.210 |
Why?
|
Toll-Like Receptor 4 | 2 | 2018 | 33 | 0.210 |
Why?
|
Lymphocytes | 1 | 2002 | 110 | 0.200 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2019 | 26 | 0.200 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2021 | 6 | 0.200 |
Why?
|
Veterans | 1 | 2022 | 63 | 0.200 |
Why?
|
Antibodies, Viral | 1 | 2021 | 87 | 0.190 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2021 | 39 | 0.190 |
Why?
|
Adult | 13 | 2020 | 8594 | 0.190 |
Why?
|
Snail Family Transcription Factors | 2 | 2011 | 5 | 0.190 |
Why?
|
Osteoarthritis, Knee | 2 | 2015 | 381 | 0.190 |
Why?
|
Carcinogenesis | 2 | 2019 | 21 | 0.190 |
Why?
|
Immunity, Innate | 1 | 2021 | 90 | 0.190 |
Why?
|
Acute-Phase Proteins | 3 | 2021 | 14 | 0.190 |
Why?
|
Occludin | 2 | 2017 | 13 | 0.190 |
Why?
|
Carbohydrates | 2 | 2015 | 14 | 0.180 |
Why?
|
Rats, Sprague-Dawley | 6 | 2011 | 452 | 0.180 |
Why?
|
Adipose Tissue | 2 | 2018 | 73 | 0.180 |
Why?
|
Colonic Polyps | 1 | 2019 | 23 | 0.180 |
Why?
|
Xeroderma Pigmentosum Group A Protein | 1 | 2019 | 4 | 0.180 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2022 | 189 | 0.180 |
Why?
|
Time Factors | 7 | 2019 | 1615 | 0.180 |
Why?
|
Osteolysis | 1 | 2020 | 149 | 0.170 |
Why?
|
Leukocytes, Mononuclear | 2 | 2014 | 96 | 0.170 |
Why?
|
Rotenone | 1 | 2018 | 10 | 0.170 |
Why?
|
Prostheses and Implants | 1 | 2020 | 166 | 0.170 |
Why?
|
Tight Junctions | 6 | 2021 | 28 | 0.170 |
Why?
|
Diet, High-Fat | 2 | 2015 | 19 | 0.170 |
Why?
|
Cell Line, Tumor | 4 | 2014 | 264 | 0.160 |
Why?
|
Forkhead Box Protein O1 | 1 | 2018 | 7 | 0.160 |
Why?
|
Wnt Signaling Pathway | 1 | 2018 | 30 | 0.160 |
Why?
|
Transcription Factor HES-1 | 1 | 2017 | 5 | 0.160 |
Why?
|
Keratin-20 | 1 | 2017 | 5 | 0.160 |
Why?
|
Jejunum | 1 | 2017 | 10 | 0.160 |
Why?
|
Chromogranin A | 1 | 2017 | 13 | 0.160 |
Why?
|
Receptor, Notch1 | 1 | 2017 | 7 | 0.160 |
Why?
|
Aged | 9 | 2021 | 9441 | 0.160 |
Why?
|
Hypercholesterolemia | 1 | 2018 | 29 | 0.160 |
Why?
|
Cadherins | 1 | 2017 | 34 | 0.160 |
Why?
|
Cell Lineage | 1 | 2017 | 29 | 0.160 |
Why?
|
Lipopolysaccharides | 2 | 2016 | 127 | 0.160 |
Why?
|
Fatty Acids | 1 | 2017 | 38 | 0.160 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 27 | 0.160 |
Why?
|
Bone and Bones | 1 | 2018 | 119 | 0.160 |
Why?
|
Prosthesis-Related Infections | 1 | 2020 | 214 | 0.160 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2016 | 56 | 0.160 |
Why?
|
Binge Drinking | 1 | 2017 | 14 | 0.160 |
Why?
|
Melatonin | 2 | 2016 | 94 | 0.160 |
Why?
|
Butyrates | 3 | 2022 | 19 | 0.150 |
Why?
|
Knee Joint | 3 | 2015 | 797 | 0.150 |
Why?
|
Methamphetamine | 1 | 2018 | 48 | 0.150 |
Why?
|
Case-Control Studies | 4 | 2021 | 636 | 0.150 |
Why?
|
Intestinal Diseases | 1 | 2017 | 9 | 0.150 |
Why?
|
Mast Cells | 2 | 2016 | 26 | 0.150 |
Why?
|
Analgesics | 1 | 2018 | 108 | 0.150 |
Why?
|
Kidney | 1 | 2018 | 173 | 0.150 |
Why?
|
Cells, Cultured | 5 | 2017 | 688 | 0.150 |
Why?
|
Arthralgia | 1 | 2018 | 121 | 0.140 |
Why?
|
Disease Susceptibility | 2 | 2015 | 80 | 0.140 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2016 | 22 | 0.140 |
Why?
|
Sleep | 2 | 2016 | 313 | 0.140 |
Why?
|
DNA-Binding Proteins | 1 | 2018 | 254 | 0.140 |
Why?
|
Risk Factors | 1 | 2022 | 2436 | 0.140 |
Why?
|
Matrix Metalloproteinase 13 | 4 | 2015 | 30 | 0.140 |
Why?
|
Sleep Disorders, Circadian Rhythm | 1 | 2016 | 39 | 0.140 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 81 | 0.140 |
Why?
|
Carbohydrate Metabolism | 1 | 2015 | 8 | 0.130 |
Why?
|
Chromatography, Gas | 1 | 2015 | 12 | 0.130 |
Why?
|
Urinalysis | 1 | 2015 | 9 | 0.130 |
Why?
|
Up-Regulation | 3 | 2011 | 177 | 0.130 |
Why?
|
Cell Line | 3 | 2011 | 301 | 0.130 |
Why?
|
Tyrosine | 2 | 2011 | 23 | 0.130 |
Why?
|
Joints | 1 | 2015 | 97 | 0.130 |
Why?
|
Fibronectins | 2 | 2005 | 29 | 0.130 |
Why?
|
Anti-Infective Agents, Local | 1 | 2015 | 52 | 0.130 |
Why?
|
Toll-Like Receptors | 1 | 2014 | 28 | 0.120 |
Why?
|
RNA, Small Interfering | 2 | 2011 | 65 | 0.120 |
Why?
|
Young Adult | 6 | 2016 | 1933 | 0.120 |
Why?
|
HIV-1 | 1 | 2018 | 438 | 0.120 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 153 | 0.120 |
Why?
|
Solid Phase Microextraction | 1 | 2013 | 4 | 0.120 |
Why?
|
Oxidants | 2 | 2011 | 28 | 0.120 |
Why?
|
Artifacts | 1 | 2013 | 32 | 0.120 |
Why?
|
Specimen Handling | 1 | 2013 | 48 | 0.120 |
Why?
|
Food Hypersensitivity | 1 | 2014 | 57 | 0.120 |
Why?
|
Hepatitis, Alcoholic | 1 | 2013 | 11 | 0.120 |
Why?
|
Hippocampus | 1 | 2015 | 276 | 0.110 |
Why?
|
Alcohol-Related Disorders | 1 | 2013 | 3 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 34 | 0.110 |
Why?
|
Bacteria | 2 | 2023 | 77 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2013 | 69 | 0.110 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 74 | 0.110 |
Why?
|
Mice, Transgenic | 3 | 2019 | 254 | 0.110 |
Why?
|
RNA, Messenger | 1 | 2013 | 326 | 0.110 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 40 | 0.110 |
Why?
|
Escherichia coli Infections | 1 | 2011 | 27 | 0.110 |
Why?
|
Cell Movement | 2 | 2009 | 105 | 0.110 |
Why?
|
Cognitive Dysfunction | 1 | 2021 | 938 | 0.100 |
Why?
|
Nitric Oxide | 2 | 2009 | 101 | 0.100 |
Why?
|
Wine | 1 | 2011 | 8 | 0.100 |
Why?
|
Escherichia coli | 1 | 2011 | 59 | 0.100 |
Why?
|
Catenins | 1 | 2011 | 1 | 0.100 |
Why?
|
Diarrhea | 1 | 2011 | 48 | 0.100 |
Why?
|
Lysine | 1 | 2011 | 13 | 0.100 |
Why?
|
Crohn Disease | 1 | 2011 | 46 | 0.100 |
Why?
|
Particulate Matter | 1 | 2011 | 22 | 0.100 |
Why?
|
p21-Activated Kinases | 1 | 2011 | 12 | 0.100 |
Why?
|
Colitis, Ulcerative | 1 | 2011 | 66 | 0.100 |
Why?
|
Gastric Mucosa | 1 | 2010 | 12 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 441 | 0.090 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2010 | 2 | 0.090 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2009 | 12 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 107 | 0.090 |
Why?
|
Avena | 1 | 2009 | 5 | 0.090 |
Why?
|
Colonic Diseases | 1 | 2009 | 12 | 0.090 |
Why?
|
Alzheimer Disease | 1 | 2021 | 1942 | 0.090 |
Why?
|
Wound Healing | 1 | 2010 | 168 | 0.090 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2022 | 13 | 0.080 |
Why?
|
Zonula Occludens-1 Protein | 3 | 2017 | 16 | 0.080 |
Why?
|
Biopsy | 3 | 2016 | 234 | 0.080 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2008 | 22 | 0.080 |
Why?
|
Extracellular Matrix | 1 | 2008 | 74 | 0.080 |
Why?
|
Proteoglycans | 3 | 2015 | 337 | 0.080 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2007 | 4 | 0.080 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 17 | 0.080 |
Why?
|
Immunologic Surveillance | 1 | 2007 | 1 | 0.080 |
Why?
|
Fungal Proteins | 1 | 2007 | 7 | 0.080 |
Why?
|
Candidiasis | 1 | 2007 | 17 | 0.080 |
Why?
|
Cell Communication | 1 | 2007 | 32 | 0.080 |
Why?
|
Leukocytes | 1 | 2007 | 43 | 0.070 |
Why?
|
Cell Adhesion | 2 | 2007 | 43 | 0.070 |
Why?
|
Immunoblotting | 1 | 2005 | 57 | 0.070 |
Why?
|
Interleukin-1 | 1 | 2005 | 78 | 0.070 |
Why?
|
Ankle Joint | 1 | 2005 | 39 | 0.070 |
Why?
|
Environment | 2 | 2015 | 46 | 0.070 |
Why?
|
Motor Activity | 2 | 2021 | 369 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 130 | 0.070 |
Why?
|
In Vitro Techniques | 1 | 2005 | 214 | 0.070 |
Why?
|
NF-kappa B | 3 | 2011 | 107 | 0.060 |
Why?
|
Brain | 3 | 2022 | 1689 | 0.060 |
Why?
|
Dextran Sulfate | 1 | 2023 | 11 | 0.060 |
Why?
|
Oxygen | 1 | 2023 | 85 | 0.060 |
Why?
|
ARNTL Transcription Factors | 1 | 2022 | 8 | 0.060 |
Why?
|
Prebiotics | 1 | 2023 | 15 | 0.060 |
Why?
|
Ileum | 2 | 2015 | 22 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2021 | 1111 | 0.050 |
Why?
|
3T3 Cells | 1 | 2002 | 11 | 0.050 |
Why?
|
Laminin | 1 | 2002 | 8 | 0.050 |
Why?
|
Acetates | 1 | 2022 | 19 | 0.050 |
Why?
|
Fibrinogen | 1 | 2002 | 19 | 0.050 |
Why?
|
Oligopeptides | 1 | 2002 | 30 | 0.050 |
Why?
|
Cell Division | 1 | 2002 | 113 | 0.050 |
Why?
|
Spleen | 1 | 2002 | 51 | 0.050 |
Why?
|
Transfection | 1 | 2002 | 125 | 0.050 |
Why?
|
Cytokines | 2 | 2016 | 347 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 145 | 0.050 |
Why?
|
Glycomics | 1 | 2021 | 5 | 0.050 |
Why?
|
Haptoglobins | 1 | 2021 | 5 | 0.050 |
Why?
|
Mice, Inbred BALB C | 1 | 2002 | 264 | 0.050 |
Why?
|
Suprachiasmatic Nucleus | 1 | 2021 | 15 | 0.050 |
Why?
|
Luciferases | 1 | 2021 | 24 | 0.050 |
Why?
|
Metabolomics | 1 | 2021 | 23 | 0.050 |
Why?
|
Protein Precursors | 1 | 2021 | 19 | 0.050 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2021 | 9 | 0.050 |
Why?
|
Complement Activation | 1 | 2021 | 13 | 0.050 |
Why?
|
Receptors, Fc | 1 | 2021 | 11 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2021 | 50 | 0.050 |
Why?
|
Spike Glycoprotein, Coronavirus | 1 | 2021 | 17 | 0.050 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 28 | 0.050 |
Why?
|
Phagocytosis | 1 | 2021 | 55 | 0.050 |
Why?
|
Glucose | 2 | 2013 | 59 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 27 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2002 | 209 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 260 | 0.050 |
Why?
|
Life Style | 1 | 2022 | 211 | 0.050 |
Why?
|
Memory, Short-Term | 1 | 2021 | 102 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2011 | 27 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2011 | 145 | 0.050 |
Why?
|
DNA Damage | 1 | 2019 | 30 | 0.040 |
Why?
|
Chronotherapy | 1 | 2019 | 9 | 0.040 |
Why?
|
Interleukin-1beta | 2 | 2010 | 55 | 0.040 |
Why?
|
CD3 Complex | 1 | 2018 | 13 | 0.040 |
Why?
|
Pandemics | 1 | 2021 | 236 | 0.040 |
Why?
|
Mutation | 2 | 2015 | 383 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 4844 | 0.040 |
Why?
|
Bone Development | 1 | 2018 | 32 | 0.040 |
Why?
|
Membrane Proteins | 2 | 2011 | 174 | 0.040 |
Why?
|
NAV1.8 Voltage-Gated Sodium Channel | 1 | 2018 | 7 | 0.040 |
Why?
|
Mutagenesis | 1 | 2018 | 12 | 0.040 |
Why?
|
Behavior, Addictive | 1 | 2018 | 11 | 0.040 |
Why?
|
Rats, Transgenic | 1 | 2018 | 21 | 0.040 |
Why?
|
Rats, Inbred F344 | 1 | 2018 | 48 | 0.040 |
Why?
|
Cytoskeleton | 2 | 2009 | 51 | 0.040 |
Why?
|
Models, Biological | 2 | 2011 | 343 | 0.040 |
Why?
|
Self Administration | 1 | 2018 | 36 | 0.040 |
Why?
|
Animal Feed | 1 | 2017 | 6 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2017 | 12 | 0.040 |
Why?
|
Protein Kinases | 1 | 2017 | 13 | 0.040 |
Why?
|
Hyperalgesia | 1 | 2018 | 46 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 48 | 0.040 |
Why?
|
Eating | 1 | 2017 | 45 | 0.040 |
Why?
|
Genotype | 1 | 2018 | 405 | 0.040 |
Why?
|
Sigmoidoscopy | 1 | 2016 | 8 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2016 | 25 | 0.040 |
Why?
|
Employment | 1 | 2016 | 42 | 0.030 |
Why?
|
Income | 1 | 2016 | 74 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2016 | 83 | 0.030 |
Why?
|
Organ Specificity | 1 | 2015 | 47 | 0.030 |
Why?
|
Protein Folding | 1 | 2015 | 18 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2016 | 69 | 0.030 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 34 | 0.030 |
Why?
|
Cohort Studies | 1 | 2021 | 1937 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 40 | 0.030 |
Why?
|
Alkanes | 1 | 2015 | 3 | 0.030 |
Why?
|
Sesquiterpenes | 1 | 2015 | 4 | 0.030 |
Why?
|
Terpenes | 1 | 2015 | 4 | 0.030 |
Why?
|
Body Weight | 1 | 2015 | 133 | 0.030 |
Why?
|
Fatty Alcohols | 1 | 2015 | 6 | 0.030 |
Why?
|
Sulfides | 1 | 2015 | 12 | 0.030 |
Why?
|
Disulfides | 1 | 2015 | 12 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2015 | 21 | 0.030 |
Why?
|
Homeostasis | 1 | 2015 | 82 | 0.030 |
Why?
|
Healthy Volunteers | 1 | 2015 | 46 | 0.030 |
Why?
|
Gastrointestinal Absorption | 1 | 2014 | 2 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 327 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2014 | 37 | 0.030 |
Why?
|
Kinetics | 1 | 2015 | 226 | 0.030 |
Why?
|
Dietary Sucrose | 1 | 2014 | 7 | 0.030 |
Why?
|
Educational Status | 1 | 2016 | 295 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2016 | 215 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 37 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2013 | 26 | 0.030 |
Why?
|
Light | 1 | 2014 | 76 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2015 | 132 | 0.030 |
Why?
|
Smoking | 1 | 2015 | 192 | 0.030 |
Why?
|
Adherens Junctions | 1 | 2013 | 4 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2022 | 3475 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 68 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 292 | 0.030 |
Why?
|
Disease Progression | 1 | 2015 | 788 | 0.030 |
Why?
|
Random Allocation | 1 | 2013 | 146 | 0.030 |
Why?
|
Cognition | 1 | 2021 | 1279 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2013 | 91 | 0.030 |
Why?
|
Body Mass Index | 1 | 2015 | 426 | 0.030 |
Why?
|
Lactulose | 1 | 2011 | 8 | 0.030 |
Why?
|
Mannitol | 1 | 2011 | 12 | 0.030 |
Why?
|
Immune System | 1 | 2011 | 19 | 0.030 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2011 | 8 | 0.030 |
Why?
|
District of Columbia | 1 | 2011 | 5 | 0.030 |
Why?
|
Electric Impedance | 1 | 2011 | 24 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2011 | 15 | 0.030 |
Why?
|
Gene Silencing | 1 | 2011 | 21 | 0.030 |
Why?
|
Air Pollution | 1 | 2011 | 17 | 0.030 |
Why?
|
Cell Death | 1 | 2011 | 61 | 0.030 |
Why?
|
Particle Size | 1 | 2011 | 78 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 84 | 0.020 |
Why?
|
Pulmonary Artery | 1 | 2011 | 43 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2011 | 109 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2011 | 125 | 0.020 |
Why?
|
Mitochondria | 1 | 2011 | 78 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2011 | 108 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2011 | 63 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 126 | 0.020 |
Why?
|
Neutrophils | 1 | 2011 | 117 | 0.020 |
Why?
|
Matrix Metalloproteinase Inhibitors | 1 | 2010 | 8 | 0.020 |
Why?
|
Anastomotic Leak | 1 | 2010 | 5 | 0.020 |
Why?
|
Antibodies | 1 | 2010 | 65 | 0.020 |
Why?
|
Peptide Mapping | 1 | 2009 | 6 | 0.020 |
Why?
|
Protein Carbonylation | 1 | 2009 | 2 | 0.020 |
Why?
|
Nitrites | 1 | 2009 | 4 | 0.020 |
Why?
|
Edible Grain | 1 | 2009 | 4 | 0.020 |
Why?
|
Nitrates | 1 | 2009 | 7 | 0.020 |
Why?
|
Peroxidase | 1 | 2009 | 18 | 0.020 |
Why?
|
Actin Cytoskeleton | 1 | 2009 | 13 | 0.020 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2008 | 1 | 0.020 |
Why?
|
raf Kinases | 1 | 2008 | 1 | 0.020 |
Why?
|
Metabolism | 1 | 2008 | 9 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2008 | 26 | 0.020 |
Why?
|
Substance P | 1 | 2008 | 18 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2008 | 22 | 0.020 |
Why?
|
Diet | 1 | 2009 | 171 | 0.020 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2007 | 5 | 0.020 |
Why?
|
Down-Regulation | 1 | 2007 | 115 | 0.020 |
Why?
|
Synovial Fluid | 1 | 2008 | 123 | 0.020 |
Why?
|
Spectrophotometry | 1 | 2007 | 5 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2007 | 43 | 0.020 |
Why?
|
Ligands | 1 | 2007 | 55 | 0.020 |
Why?
|
Species Specificity | 1 | 2007 | 70 | 0.020 |
Why?
|
Actins | 1 | 2007 | 47 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2007 | 85 | 0.020 |
Why?
|
Gene Expression | 1 | 2007 | 226 | 0.020 |
Why?
|
Protein Binding | 1 | 2007 | 128 | 0.020 |
Why?
|
Cattle | 1 | 2007 | 217 | 0.020 |
Why?
|
Chronic Disease | 1 | 2008 | 495 | 0.020 |
Why?
|
Surveys and Questionnaires | 1 | 2011 | 1181 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2008 | 358 | 0.020 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2003 | 1 | 0.010 |
Why?
|
Integrin alpha5beta1 | 1 | 2003 | 2 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2003 | 21 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2003 | 44 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 114 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2003 | 99 | 0.010 |
Why?
|